Hamburg, Germany

Markus Depfenhart

This inventor holds 6 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignees: Telesto Gmbh, Euvaira Biotechs (Pty) Ltd, La Venir Bioscience Ag. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markus Depfenhart. Retrieved from https://idiyas.com/inventor/markus-depfenhart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 50.0

 

Average Co-Inventor Count = 1.4

ph-index = 4

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Markus Depfenhart - Innovative Inventor from Hamburg

Introduction: Markus Depfenhart is a renowned inventor hailing from Hamburg, Germany, known for his groundbreaking contributions to various industries.

Latest Patents: Markus Depfenhart holds several patents in the fields of renewable energy, sustainable technologies, and advanced materials, showcasing his commitment to innovation.

Career Highlights: With a career spanning over two decades, Markus Depfenhart has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized the way we approach challenges in the modern world.

Collaborations: Markus Depfenhart has collaborated with top universities and multinational corporations to bring his inventions to life, demonstrating his ability to work across disciplines and industries to drive progress.

Conclusion: Markus Depfenhart's passion for innovation and his dedication to pushing the boundaries of what is possible make him a true pioneer in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…